Sanofi to unveil plans for French research shake-up
PARIS (Reuters) - French drugmaker Sanofi will reveal on Tuesday how it plans to shake up its French research operations in a cost-cutting drive which unions predict could mean up...
Home > Reviews
All Stories
Sanofi to unveil plans for French research shake-up
PARIS (Reuters) - French drugmaker Sanofi will reveal on Tuesday how it plans to shake up its French research operations in a cost-cutting drive which unions predict could mean up...
France’s Cite du Cinema aims to lure Hollywood
PARIS (Reuters) - French director Luc Besson has realized his dream of building a world class film complex on the banks of the Seine. Now the only question is whether...
France’s Cite du Cinema aims to lure Hollywood
PARIS (Reuters) - French director Luc Besson has realized his dream of building a world class film complex on the banks of the Seine. Now the only question is whether...
Sanofi multiple sclerosis pill wins U.S. approval
PARIS (Reuters) - Sanofi SA has won U.S. approval for its multiple sclerosis (MS) pill Aubagio, one of the two treatments for the chronic disease that could return the French...
Sanofi multiple sclerosis pill wins U.S. approval
PARIS (Reuters) - Sanofi SA has won U.S. approval for its multiple sclerosis (MS) pill Aubagio, one of the two treatments for the chronic disease that could return the French...
Low-profile Peugeot family keep grip on the wheel
PARIS (Reuters) - PSA Peugeot Citroen claims to be the world's oldest car maker thanks to a wealthy, close-knit clan that has steered the business since 1810, but Europe's number...
Low-profile Peugeot family keep grip on the wheel
PARIS (Reuters) - PSA Peugeot Citroen claims to be the world's oldest car maker thanks to a wealthy, close-knit clan that has steered the business since 1810, but Europe's number...
Sanofi strong in emerging markets as rivals flag
PARIS (Reuters) - French drugmaker Sanofi posted better-than-expected quarterly results, bolstered by strong emerging markets, breaking with a trend of earnings misses by European rivals AstraZeneca and GlaxoSmithkline. Sanofi performed...
Sanofi strong in emerging markets as rivals flag
PARIS (Reuters) - French drugmaker Sanofi posted better-than-expected quarterly results, bolstered by strong emerging markets, breaking with a trend of earnings misses by European rivals AstraZeneca and GlaxoSmithkline. Sanofi performed...